Ciliary G-Protein Coupled Receptor Signaling in Polycystic Kidney Disease. [PDF]
Buqaileh R, Alshriem LA, AbouAlaiwi W.
europepmc +1 more source
Safety and efficacy of tolvaptan in real‑world Japanese patients with autosomal dominant polycystic kidney disease: final results of SLOW‑PKD surveillance. [PDF]
Mochizuki T+6 more
europepmc +1 more source
Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction
Yuya Matsue+15 more
openalex +1 more source
FP047POTENTIAL IMPACT OF TOLVAPTAN ON BLOOD PRESSURE IN THE TEMPO 3:4 PATIENT POPULATION [PDF]
Arlene B. Chapman+6 more
openalex +1 more source
Recurrent hyponatremia due to syndrome of inappropriate antidiuresis after traumatic brain injury: two case reports. [PDF]
Petria I+5 more
europepmc +1 more source
Tolvaptan regulates aquaporin-2 and fecal water in cirrhotic rats with ascites
Chao Chen+5 more
openalex +1 more source
Long-term Tolvaptan Treatment of Autosomal Dominant Polycystic Kidney Disease in Korea [PDF]
Ha Yeon Kim+6 more
openalex +1 more source
Importance of early use of tolvaptan in hyponatremic acutely decompensated heart failure patients, a retrospective study. [PDF]
Soerarso R+8 more
europepmc +1 more source